{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:36:35Z","timestamp":1790753795284,"version":"4.1.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NRF2016-CRP001-103"],"award-info":[{"award-number":["NRF2016-CRP001-103"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NRF2019-NRF-ISF003-3127"],"award-info":[{"award-number":["NRF2019-NRF-ISF003-3127"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NRF-NRFF2017-03"],"award-info":[{"award-number":["NRF-NRFF2017-03"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H18\/01\/a0\/022"],"award-info":[{"award-number":["H18\/01\/a0\/022"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CIRG\/1427\/2015"],"award-info":[{"award-number":["NMRC\/CIRG\/1427\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/OFLCG\/003\/2018"],"award-info":[{"award-number":["NMRC\/OFLCG\/003\/2018"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/TCR\/014-NUHS\/2015"],"award-info":[{"award-number":["NMRC\/TCR\/014-NUHS\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Viral hepatitis particularly Hepatitis B Virus (HBV) is still an ongoing health issue worldwide. Despite the vast technological advancements in research and development, only HBV vaccines, typically given during early years, are currently available as a preventive measure against acquiring the disease from a secondary source. In general, HBV can be cleared naturally by the human immune system if detected at low levels early. However, long term circulation of HBV in the peripheral blood may be detrimental to the human liver, specifically targeting human hepatocytes for cccDNA integration which inevitably supports HBV life cycle for the purpose of reinfection in healthy cells. Although there is some success in using nucleoside analogs or polyclonal antibodies targeting HBV surface antigens (HBsAg) in patients with acute or chronic HBV<jats:sup>+<\/jats:sup> (CHB), majority of them would either respond only partially or succumb to the disease entirely unless they undergo liver transplants from a fully matched healthy donor and even so may not necessarily guarantee a 100% chance of survival. Indeed, <jats:italic>in vitro\/ex vivo<\/jats:italic> cultures and various transgenic animal models have already provided us with a good understanding of HBV but they primarily lack human specificity or virus-host interactions in the presence of human immune surveillance. Therefore, the demand of utilizing humanized mice has increased over the last decade as a pre-clinical platform for investigating human-specific immune responses against HBV as well as identifying potential immunotherapeutic strategies in eradicating the virus. Basically, this review covers some of the recent developments and key advantages of humanized mouse models over other conventional transgenic mice platforms.<\/jats:p>","DOI":"10.3389\/fimmu.2021.638447","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T23:32:09Z","timestamp":1613863929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Establishment of Humanized Mice for the Study of HBV"],"prefix":"10.3389","volume":"12","author":[{"given":"Fritz","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry Yong Yi","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"B1","first-page":"p. 83","volume-title":"April 2017 Global Hepatitis Report","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.21037\/hbsn.2017.05.02","article-title":"Addressing the increasing global burden of viral hepatitis","volume":"6","author":"Brown","year":"2017","journal-title":"Hepatobiliary Surg Nutr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"a021436","DOI":"10.1101\/cshperspect.a021436","article-title":"Hepatitis B virus genotypes and variants","volume":"5","author":"Lin","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B virus infection: overview","volume":"1179","author":"Li","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.vaccine.2013.10.057","article-title":"Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review","volume":"32","author":"Ang","year":"2013","journal-title":"Vaccine."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions\u2013report of the ANRS workshop on HBV cure","volume":"64","author":"Zeisel","year":"2015","journal-title":"Gut."},{"key":"B7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/v12050515","article-title":"the lived experience of chronic hepatitis B: a broader view of its impacts and why we need a cure","volume":"12","author":"Tu","year":"2020","journal-title":"Viruses."},{"key":"B8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/v10110643","article-title":"Humanized mouse models for the study of infection and pathogenesis of human viruses","volume":"10","author":"Lai","year":"2018","journal-title":"Viruses."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-981-13-9151-4_5","article-title":"Cell culture models and animal models for HBV study","volume":"1179","author":"Li","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1128\/JVI.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","author":"Newbold","year":"1995","journal-title":"J Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.1128\/JVI.01024-14","article-title":"Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice","volume":"88","author":"Qi","year":"2014","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.26428","article-title":"Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island","volume":"58","author":"Dupinay","year":"2013","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1128\/JVI.75.11.5084-5089.2001","article-title":"Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus","volume":"75","author":"Kock","year":"2001","journal-title":"J Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF01261404","article-title":"Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus","volume":"122","author":"Yan","year":"1996","journal-title":"J Cancer Res Clin Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cld.2007.08.012","article-title":"The role of the woodchuck model in the treatment of hepatitis B virus infection","volume":"11","author":"Kulkarni","year":"2007","journal-title":"Clin Liver Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/hep.1840220443","article-title":"Hepatitis B virus transgenic mice: insights into the virus and the disease","volume":"22","author":"Chisari","year":"1995","journal-title":"Hepatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1073\/pnas.0409028102","article-title":"Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs","volume":"102","author":"Uprichard","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.23602","article-title":"Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2014","journal-title":"Cell Mol Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/hep.29406","article-title":"Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1699-0463.1969.tb04520.x","article-title":"Heterotransplantation of a human malignant tumour to \u201cNude\u201d mice","volume":"77","author":"Rygaard","year":"1969","journal-title":"Acta Pathol Microbiol Scand."},{"key":"B28","doi-asserted-by":"publisher","first-page":"a021477","DOI":"10.1101\/cshperspect.a021477","article-title":"Mouse models of hepatitis B virus pathogenesis","volume":"5","author":"Iannacone","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1053\/j.gastro.2013.09.009","article-title":"Mice with human livers","volume":"145","author":"Grompe","year":"2013","journal-title":"Gastroenterology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2014.03.002","article-title":"Mouse models of hepatitis B and delta virus infection","volume":"410","author":"Dandri","year":"2014","journal-title":"J Immunol Methods."},{"key":"B31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.510290228","article-title":"The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents","volume":"29","author":"Ilan","year":"1999","journal-title":"Hepatology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0092-8674(91)90615-6","article-title":"Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene","volume":"66","author":"Sandgren","year":"1991","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0092-8674(90)90010-C","article-title":"Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator","volume":"62","author":"Heckel","year":"1990","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-2006-939760","article-title":"Small animal model systems for studying hepatitis B virus replication and pathogenesis","volume":"26","author":"Dandri","year":"2006","journal-title":"Semin Liver Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3851\/IMP2075","article-title":"Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA\/SCID mice","volume":"17","author":"Volz","year":"2012","journal-title":"Antivir Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e25096","DOI":"10.1371\/journal.pone.0025096","article-title":"Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA\/SCID mice","volume":"6","author":"Brezillon","year":"2011","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.antiviral.2008.07.006","article-title":"The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV HCV","volume":"80","author":"Meuleman","year":"2008","journal-title":"Antiviral Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"Lutgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhep.2010.03.024","article-title":"Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice","volume":"53","author":"Vanwolleghem","year":"2010","journal-title":"J Hepatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"Grompe","year":"1993","journal-title":"Genes Dev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ng0396-266","article-title":"Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I","volume":"12","author":"Overturf","year":"1996","journal-title":"Nat Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1128\/JVI.02010-06","article-title":"Human immunodeficiency virus type 1 pathobiology studied in humanized BALB\/c-Rag2-\/-gammac-\/- mice","volume":"81","author":"Gorantla","year":"2007","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1073\/pnas.92.13.6210","article-title":"Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo","volume":"92","author":"Lieber","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31282","article-title":"Functional comparison of IFN-alpha subtypes reveals potent HBV suppression by a concerted action of IFN-alpha and -gamma SIgnaling","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted 'humanized liver' in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbrc.2013.10.040","article-title":"A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections","volume":"441","author":"Kosaka","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"27782","DOI":"10.1038\/srep27782","article-title":"Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver","volume":"6","author":"Nakabori","year":"2016","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/COH.0000000000000616","article-title":"In-vitro and in-vivo models for hepatitis B cure research","volume":"15","author":"Allweiss","year":"2020","journal-title":"Curr Opin HIV AIDS"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/stem.1359","article-title":"Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem\/progenitor cells","volume":"31","author":"Chen","year":"2013","journal-title":"Stem Cells"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307856","article-title":"Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infection","volume":"65","author":"Keng","year":"2016","journal-title":"Gut"},{"key":"B57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jhep.2017.04.023","article-title":"Intrahepatic CD206(+) macrophages contribute to inflammation in advanced viral-related liver disease","volume":"67","author":"Tan-Garcia","year":"2017","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.jhepr.2019.11.006","article-title":"Liver fibrosis and CD206(+) macrophage accumulation are suppressed by anti-GM-CSF therapy","volume":"2","author":"Tan-Garcia","year":"2020","journal-title":"JHEP Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.22.215640","article-title":"Selective Expression of variant surface antigens enables Plasmodium falciparum to evade immune clearance in vivo","author":"Chew","year":"2020","journal-title":"bioRxiv [Preprint]"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J Hepatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/nprot.2012.083","article-title":"Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis","volume":"7","author":"Bility","year":"2012","journal-title":"Nat Protoc"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e1004032","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"key":"B64","doi-asserted-by":"publisher","first-page":"13022","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice","volume":"107","author":"Shultz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B65","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.4049\/jimmunol.1201625","article-title":"Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes\/macrophages by interfering with JNK activation","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/2681","article-title":"Selective repopulation of normal mouse liver by Fas\/CD95-resistant hepatocytes","volume":"4","author":"Mignon","year":"1998","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/jhep.2001.20678","article-title":"Fas\/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer","volume":"33","author":"Guidotti","year":"2001","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.coviro.2017.07.029","article-title":"Modeling hepatitis virus infections and treatment strategies in humanized mice","volume":"25","author":"Kremsdorf","year":"2017","journal-title":"Curr Opin Virol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajpath.2013.09.008","article-title":"Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice","volume":"184","author":"Gutti","year":"2014","journal-title":"Am J Pathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1016\/j.yexcr.2009.07.007","article-title":"The role of HGF on invasive properties and repopulation potential of human fetal hepatic progenitor cells","volume":"315","author":"Delgado","year":"2009","journal-title":"Exp Cell Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol Rev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clim.2011.02.019","article-title":"Human T cell development in the liver of humanized NOD\/SCID\/IL-2Rgamma(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells","volume":"139","author":"Choi","year":"2011","journal-title":"Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.4049\/jimmunol.1202810","article-title":"Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation","volume":"190","author":"Lang","year":"2013","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gene.2012.16","article-title":"Human B-cell ontogeny in humanized NOD\/SCID gammac(null) mice generates a diverse yet auto\/poly- and HIV-1-reactive antibody repertoire","volume":"13","author":"Chang","year":"2012","journal-title":"Genes Immun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.4049\/jimmunol.1000438","article-title":"CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice","volume":"184","author":"Gorantla","year":"2010","journal-title":"J Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ni1527","article-title":"Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1634\/stemcells.2008-0583","article-title":"Busulfan produces efficient human cell engraftment in NOD\/LtSz-Scid IL2Rgamma(null) mice","volume":"27","author":"Hayakawa","year":"2009","journal-title":"Stem Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/mt.2013.29","article-title":"Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation","volume":"21","author":"Wilkinson","year":"2013","journal-title":"Mol Ther"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0119820","DOI":"10.1371\/journal.pone.0119820","article-title":"A novel mouse model for stable engraftment of a human immune system and human hepatocytes","volume":"10","author":"Strick-Marchand","year":"2015","journal-title":"PLoS ONE"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.08.034","article-title":"Viral load affects the immune response to HBV in mice with humanized immune system and liver","author":"Dusseaux","year":"2017","journal-title":"Gastroenterology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus\u2013specific global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2008.10.047","article-title":"Differentiation and transplantation of human embryonic stem cell-derived hepatocytes","volume":"136","author":"Basma","year":"2009","journal-title":"Gastroenterology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J Hepatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3389\/fmicb.2018.00908","article-title":"A chimeric humanized mouse model by engrafting the human induced pluripotent stem cell-derived hepatocyte-like cell for the chronic hepatitis B virus infection","volume":"9","author":"Yuan","year":"2018","journal-title":"Front Microbiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1172\/JCI75456","article-title":"Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model","volume":"124","author":"Carpentier","year":"2014","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.celrep.2018.01.087","article-title":"A roadmap for human liver differentiation from pluripotent stem cells","volume":"22","author":"Ang","year":"2018","journal-title":"Cell Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.stem.2009.12.001","article-title":"Vitamin C enhances the generation of mouse and human induced pluripotent stem cells","volume":"6","author":"Esteban","year":"2010","journal-title":"Cell Stem Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1136\/gutjnl-2018-316091","article-title":"HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation","volume":"68","author":"Yuan","year":"2019","journal-title":"Gut"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.638447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T23:32:13Z","timestamp":1613863933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.638447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":91,"alternative-id":["10.3389\/fimmu.2021.638447"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.638447","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"article-number":"638447"}}